Michael Rawlins
Direktor/Vorstandsmitglied bei ITI, Inc. (New York)
Aktive Positionen von Michael Rawlins
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ITI, Inc. (New York) | Direktor/Vorstandsmitglied | 01.06.2021 | - |
Präsident | - | 01.06.2021 | |
UK Biobank Ltd.
UK Biobank Ltd. Miscellaneous Commercial ServicesCommercial Services UK Biobank Ltd. is a biomedical database and research resource that contains genetic, lifestyle, and health information from half a million participants aged between 40-69 years in 2006-2010 from across the UK. The organization has over 220 dedicated members of staff, based in multiple locations across the UK. UK Biobank's research resource is a major contributor to the advancement of modern medicine and treatment, enabling better understanding of the prevention, diagnosis, and treatment of a wide range of serious and life-threatening illnesses, including cancer, heart diseases, and stroke. The non-profit company is based in Stockport, UK, and has subsidiaries in the United Kingdom. The database includes blood samples, heart and brain scans, and genetic data that are accessible to approved researchers who are undertaking health-related research that is in the public interest. The CEO of the British company is Rory Collins. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Michael Rawlins
Ehemalige bekannte Positionen von Michael Rawlins
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Medicines & Healthcare Products Regulatory Agency | Vorsitzender | - | 01.01.2020 |
INTRA-CELLULAR THERAPIES, INC. | Direktor/Vorstandsmitglied | 05.09.2013 | 31.12.2014 |
Independent Dir/Board Member | 29.08.2013 | 31.12.2014 | |
The Royal Society of Medicine
The Royal Society of Medicine Miscellaneous Commercial ServicesCommercial Services The Royal Society of Medicine provides postgraduate medical education. The Society provides a range of educational activities and opportunities for doctors, dentists and veterinary surgeons, including students, and for allied healthcare professionals. It also promotes an exchange of information and ideas on the science, practice and organization of medicine, both within the health professions and with responsible and informed public opinion. The Society was founded in 1805 and is headquartered in London, the United Kingdom. | Präsident | 01.01.2012 | 01.01.2014 |
Intra-Cellular Therapies, Inc. /Old/
Intra-Cellular Therapies, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Intra-Cellular Therapies, Inc. operates as a biopharmaceutical company which focuses on the discovery and clinical development of innovative, small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system. The company's technology addresses diseases of the central nervous system, including schizophrenia, cognition, Parkinson's disease, anxiety, depression, Alzheimer's disease, sleep, and those related to women's health. Its products include clinical development plan for schizophrenia and unique mechanism of action. Intra-Cellular Therapies was founded by Paul Greengard, Sharon Mates and Allen A. Fienberg on May 22, 2001 and is headquartered in New York, NY. | Direktor/Vorstandsmitglied | 14.05.2013 | 26.09.2013 |
Independent Dir/Board Member | 14.05.2013 | 26.09.2013 | |
National Institute for Health & Care Excellence
National Institute for Health & Care Excellence Services to the Health IndustryHealth Services National Institute for Health & Care Excellence provides national guidance and advice to improve health and social care. The firm's programs include financial planning, advice, shared learning, standards and indicators and topic selections. The company was founded in 1999 and is headquartered in London, the United Kingdom. | Vorsitzender | 01.03.2013 | 01.03.2013 |
INTRA-CELLULAR THERAPIES, INC. | Direktor/Vorstandsmitglied | 21.06.2021 | - |
Independent Dir/Board Member | 21.06.2021 | - | |
Newcastle University | Corporate Officer/Principal | - | - |
░░░ ░░░░░ ░░░░░░░ ░░ ░░░░░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ | - |
Statistik
International
Vereinigtes Königreich | 6 |
Vereinigte Staaten | 4 |
Operativ
Director/Board Member | 5 |
President | 3 |
Independent Dir/Board Member | 3 |
Sektoral
Commercial Services | 3 |
Health Technology | 3 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
INTRA-CELLULAR THERAPIES, INC. | Health Technology |
Private Unternehmen | 6 |
---|---|
The Royal Society of Medicine
The Royal Society of Medicine Miscellaneous Commercial ServicesCommercial Services The Royal Society of Medicine provides postgraduate medical education. The Society provides a range of educational activities and opportunities for doctors, dentists and veterinary surgeons, including students, and for allied healthcare professionals. It also promotes an exchange of information and ideas on the science, practice and organization of medicine, both within the health professions and with responsible and informed public opinion. The Society was founded in 1805 and is headquartered in London, the United Kingdom. | Commercial Services |
Intra-Cellular Therapies, Inc. /Old/
Intra-Cellular Therapies, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Intra-Cellular Therapies, Inc. operates as a biopharmaceutical company which focuses on the discovery and clinical development of innovative, small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system. The company's technology addresses diseases of the central nervous system, including schizophrenia, cognition, Parkinson's disease, anxiety, depression, Alzheimer's disease, sleep, and those related to women's health. Its products include clinical development plan for schizophrenia and unique mechanism of action. Intra-Cellular Therapies was founded by Paul Greengard, Sharon Mates and Allen A. Fienberg on May 22, 2001 and is headquartered in New York, NY. | Health Technology |
National Institute for Health & Care Excellence
National Institute for Health & Care Excellence Services to the Health IndustryHealth Services National Institute for Health & Care Excellence provides national guidance and advice to improve health and social care. The firm's programs include financial planning, advice, shared learning, standards and indicators and topic selections. The company was founded in 1999 and is headquartered in London, the United Kingdom. | Health Services |
ITI, Inc. (New York) | |
UK Biobank Ltd.
UK Biobank Ltd. Miscellaneous Commercial ServicesCommercial Services UK Biobank Ltd. is a biomedical database and research resource that contains genetic, lifestyle, and health information from half a million participants aged between 40-69 years in 2006-2010 from across the UK. The organization has over 220 dedicated members of staff, based in multiple locations across the UK. UK Biobank's research resource is a major contributor to the advancement of modern medicine and treatment, enabling better understanding of the prevention, diagnosis, and treatment of a wide range of serious and life-threatening illnesses, including cancer, heart diseases, and stroke. The non-profit company is based in Stockport, UK, and has subsidiaries in the United Kingdom. The database includes blood samples, heart and brain scans, and genetic data that are accessible to approved researchers who are undertaking health-related research that is in the public interest. The CEO of the British company is Rory Collins. | Commercial Services |
Medicines & Healthcare Products Regulatory Agency | Government |
- Börse
- Insiders
- Michael Rawlins
- Erfahrung